SEC Form 13F

Knoll Capital Management, LLC 13F Holdings

Inspect Knoll Capital Management, LLC's 2026-06-30 SEC 13F positions, public filing date, amendments and original receipt.

As of 2026-08-15T03:59:59.999Z

Report period
2026-06-30
Publicly available
2026-08-15
Reported value
$179,307,999
Positions
37

Disclosed positions

MeiraGTX HoldingsMGTXCOM$16,887,5001,250,000SHNone
Sprott physical gold TrustPHYSPhysical Gold Tr$11,677,449387,055SHNone
Aldeyra Therapeutics IncALDXCOM$11,662,8495,475,516SHNone
Ocular Therapeutix Inc.OCULCOM$11,296,9281,150,400SHNone
Royal Gold Inc.RGLDCOM$10,529,42752,750SHNone
Entera Bio LtdUnresolvedSHS$10,410,9255,881,879SHNone
Nuvation Bio IncNUVBCOM CL A$9,079,9961,598,591SHNone
Agnico Eagle Mines LtdAEMCOM$8,183,10752,750SHNone
SEABRIDGE GOLD INCSEACOM$8,159,657317,003SHNone
Kinross Gold CorpKGCCOM$7,558,400320,000SHNone
OR RoyaltiesORCOM SHS$7,116,750225,000SHNone
SSR Mining InSSRMCOM$6,928,600245,000SHNone
Franco Nev CorpFNVCOM$6,670,08032,000SHNone
Booz Allen Hamilton HLDG CORBAHCL A$5,693,74013,000SHNone
Centerra Gold IncCGAUCOM$5,693,740359,000SHNone
Elicio Therapeutics IncELTXCOM$4,738,7511,211,957SHNone
Abivax SA SponsABVXSPONS ADS$4,664,10035,000SHNone
Pan American SilverPAASCOM$4,480,567100,035SHNone
Sprott Physical silver TrustPSLVPhysical Silver$4,192,159222,160SHNone
Triple Flag Precious MetalsTFPMCOM$3,446,550115,000SHNone
Abeona TherapeuticsABEOCOM NEW$3,000,482485,515SHNone
Gold RTY CorpGROYCOM$2,760,0001,000,000SHNone
New Pac Metals CorpNEWPCOM$1,949,700485,000SHNone
iSHares US Aerospace & DefenseITAUS AER DEF ETF$1,854,5137,650SHNone
Philip Morris Intl. IncPMCOM$1,809,10010,000SHNone
Coeur Mining IncCDECOM NEW$1,568,87496,132SHNone
Alamos Gold IncAGICOM CL New$1,517,00050,000SHNone
Wheaton Precious Metals CorpWPMCOM$1,404,00012,500SHNone
Northrop Grumman CorpNOCCOM$1,102,6562,165SHNone
Elemental RTY CorpELECOM NEW$873,00050,000SHNone
Versamet Royalties CorpVMETCOM NEW$820,66866,621SHNone
Dakota Gold CorpDCCOM$523,643122,921SHNone
Amrize LTDAMRZSHS$489,0279,175SHNone
Altimmune IncALTCOM NEW$486,400160,000SHNone
Pharming Group NVPHARSPON ADS$56,8234,091SHNone
Orgenesis, Inc.UnresolvedCOM$20,82350,623SHNone
Biohaven Pharmactl Hldg CoUnresolvedCOM$152,328,602SHNone

Largest 50 positions by reported value; the filing may contain more positions.

How amendments affect these holdings

This view uses 1 effective filing version(s). A restatement replaces the previous book; a new-holdings amendment adds positions. 3 positions lack a resolved ticker and 0 positions are put or call entries.

A 13F is a delayed quarterly snapshot of disclosed holdings. It is not a complete trade ledger and does not reveal every position in a manager's portfolio. Option values refer to the reported underlying position rather than a traded option premium.

Quarter end and public filing date

Use the filing's public availability date when constructing a historical observation. The quarter-end report period is earlier and cannot be substituted for when the public learned the holdings.